Predictive scoring model of mortality in Gram-negative bloodstream infection

Clinical Microbiology and Infection

Volumn 19, Issue 10, 2013, Pages 948-954

  Al Hasan, M N ^a,b   Lahr, B D ^c   Eckel Passow, J E ^c   Baddour, L M ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MAYO CLINIC   (United States)

^c Mayo Clinic   (United States)

Author keywords

Bacteraemia; Outcome; Pitt bacteraemia score; Risk factors; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BLOODSTREAM INFECTION; CATHETER INFECTION; CENTRAL VENOUS CATHETER INFECTION; FEMALE; GRAM NEGATIVE BLOODSTREAM INFECTION; HUMAN; LABORATORY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; RISK FACTOR; SCORING SYSTEM; URINARY TRACT INFECTION;

NEGIBACTERIA;

BACTERAEMIA; OUTCOME; PITT BACTERAEMIA SCORE; RISK FACTORS; SEPSIS;

AGED; AGED, 80 AND OVER; BACTEREMIA; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MINNESOTA; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84884714750     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12085     Document Type: Article

References (28)

1. Knaus WA, Wagner DP, Draper EA et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-1636.
2. Al-Hasan MN, Wilson JW, Lahr BD et al. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother 2009; 53: 1386-1394.
3. Korvick JA, Bryan CS, Farber B et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother 1992; 36: 2639-2644.
4. Paterson DL, Ko WC, Von Gottberg A et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004; 140: 26-32.
5. Rhee JY, Kwon KT, Ki HK et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock 2009; 31: 146-150.
6. Pedersen G, Schonheyder HC, Sorensen HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia-a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect 2003; 9: 793-802.
7. Kang CI, Kim SH, Park WB et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49: 760-766.
8. Cagatay AA, Ozcan PE, Gulec L et al. Risk factors for mortality of nosocomial bacteraemia in intensive care units. Med Princ Pract 2007; 16: 187-192.
9. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999; 11: 7-12.
10. Pedersen G, Schonheyder HC, Sorensen HT. Antibiotic therapy and outcome of monomicrobial gram-negative bacteraemia: a 3-year population-based study. Scand J Infect Dis 1997; 29: 601-606.
11. Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect 2008; 14: 1041-1047.
12. Cheong HS, Lee JA, Kang CI et al. Risk factors for mortality and clinical implications of catheter-related infections in patients with bacteraemia caused by Stenotrophomonas maltophilia. Int J Antimicrob Agents 2008; 32: 538-540.
13. Lai CH, Chi CY, Chen HP et al. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 2004; 37: 350-358.
14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
15. Harrell FE Jr. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York, NY: Springer, 2001.
16. Al-Hasan MN, Wilson JW, Lahr BD, Eckel-Passow JE, Baddour LM. Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med 2008; 121: 702-708.
17. Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
18. Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med 2009; 122: 866-873.
19. Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect 2008; 70: 101-108.
20. Chen SY, Tsai CL, Lin CH et al. Impact of liver cirrhosis on mortality in patients with community-acquired bacteremia. Diagn Microbiol Infect Dis 2009; 64: 124-130.
21. Kang CI, Song JH, Chung DR et al. Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia. J Infect 2011; 63: 336-343.
22. Chang TY, Lee CH, Liu JW. Clinical characteristics and risk factors for fatality in patients with bloodstream infections caused by glucose non-fermenting gram-negative bacilli. J Microbiol Immunol Infect 2010; 43: 233-239.
23. Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol 2007; 102: 1510-1517.
24. Kumar A, Roberts D, Wood KE et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596.
25. Rodriguez-Bano J, de Cueto M, Retamar P, Galvez-Acebal J. Current management of bloodstream infections. Expert Rev Anti Infect Ther 2010; 8: 815-829.
26. Al-Hasan MN, Eckel-Passow JE, Baddour LM. Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infection. Epidemiol Infect 2011; 139: 1750-1756.
27. Al-Hasan MN, Eckel-Passow JE, Baddour LM. Recurrent gram-negative bloodstream infection: a 10-year population-based cohort study. J Infect 2010; 61: 28-33.
28. Leibovici L, Paul M, Poznanski O et al. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 1997; 41: 1127-1133.